InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Mirabelli Christopher. Officer active across 1 company, notably Leap Therapeutics, INC.. In total, 3 disclosures have been recorded. History available since 13 November 2024. The latest transaction was filed on 13 November 2024 (X). Regulator: SEC (Form 4). The full history is accessible without signup.
3 of 3 declarations